Streamline Health Solutions, In found using ticker (STRM) have now 2 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The range between the high target price and low target price is between 3 and 2 calculating the mean target price we have 2.5. Now with the previous closing price of 1.63 this indicates there is a potential upside of 53.4%. There is a 50 day moving average of 1.61 and the 200 day moving average is 1.43. The market capitalisation for the company is $52m. Find out more information at: http://www.streamlinehealth.net
The potential market cap would be $79m based on the market concensus.
Streamline Health Solutions provides health information technology solutions and associated services for hospitals and health systems in the United States and Canada. It provides computer software-based solutions and auditing services, which captures, aggregates, and translates structured and unstructured data to deliver predictive insights. The company also offers health information management; coding and clinical documentation improvement (CDI) solutions, which includes integrated cloud-based software suite, such as computer-assisted coding, CDI, and abstracting and physician query; and eValuator, a cloud-based pre- and post-bill coding analysis platform. In addition, it provides financial management solutions, including accounts receivable management, denials management, claims processing, spend management, and audit management; patient care solutions; and custom integration, training, electronic image conversion, audit, and database monitoring services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions was founded in 1989 and is headquartered in Alpharetta, Georgia.
